Winter Deals väntar – Shoppa nu!

Winter Deals väntar – Shoppa nu!

Fri Frakt över 299kr
Fri Frakt över 299kr
Kundservice
Emerging Therapies Targeting the Pathophysiology of Sickle Cell Disease, An Issue of Hematology/Oncology Clinics

Emerging Therapies Targeting the Pathophysiology of Sickle Cell Disease, An Issue of Hematology/Oncology Clinics

911 kr

911 kr

I lager

Fre, 10 jan - tor, 16 jan


Säker betalning

Öppet köp till och med 7/1-25


Säljs och levereras av

Adlibris


Produktbeskrivning

This issue of Hematology/Oncology Clinics, guest edited by Dr. Elliott Vichinsky, is devoted to Sickle Cell Disease, and focuses on pathophysiology of hemoglobinopathies, therapeutic targets, and new approaches to correcting ineffective erythropoiesis and iron dysregulation. Articles in this issue include Polymerization and red cell membrane changes; Overview on reperfusion injury in the pathophysiology of SCD; Regulation of ineffective erythropoiesis in iron metabolism; Altering oxygen affinity; Cellular adhesion and the endothelium; Arginine therapy; Role of the hemostatic system on SCD pathophysiology and potential therapeutics; Adenosine signaling and novel therapies; New approaches to correcting ineffective erythropoiesis and iron dysregulation; New approaches to correcting ineffective erythropoiesis and iron dysregulation; Fetal hemoglobin induction; Gene therapy for hemoglobinopathies; and Oxidative injury and the role of antioxidant therapy.

Artikel.nr.

7c06c38c-f8a3-45dc-be49-bd5cf418d3e9

Emerging Therapies Targeting the Pathophysiology of Sickle Cell Disease, An Issue of Hematology/Oncology Clinics

911 kr

911 kr

I lager

Fre, 10 jan - tor, 16 jan


Säker betalning

Öppet köp till och med 7/1-25


Säljs och levereras av

Adlibris